Resmed have announced a new share repurchase program of $US20m shares (14% of common stock US). Filed an announcement with US Securities and Exchange Commission yesterday referring to a decision made by the board on 21 February. This $20m program supersedes the previous program, it has no fixed schedule or timeframe for the repurchases.
This should give Resmed shares a needed lift. Turnaround from a continued negative slide to positive territory on US market after news was out. Also, Peter Farrell exercised some of his share options adding to his stake in RMD.
Good news, I think!
resmed share repurchase program
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$38.40 |
Change
-0.190(0.49%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $38.40 | $38.58 | $38.30 | $19.94M | 518.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 906 | $38.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $38.49 | 313 | 1 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
